Combination of a Glucagon-Like Peptide 1 Analog and a Sodium-Glucose Cotransporter 2 Inhibitor Improves Lipid Metabolism Compared to the Monotherapies in Experimental Metabolic Syndrome

Journal of Endocrinology and Metabolism · Published 2022-12-01 · DOI 10.14740/jem843

Authors being retrieved — see the publisher record. https://doi.org/10.14740/jem843

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2022

Related articles